CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
Cell therapy, involving adult stem cells from bone marrow, has been shown to reduce the risk of heart attack and stroke in severe heart failure patients, according to a new study. A single ...
Share on Pinterest Tackling hypertension, high cholesterol may help prevent heart attack, stroke, new research confirms. Image credit: Raymond Forbes LLC/Stocksy Cardiovascular diseases, such as heart ...
Adam Ennamli is Chief Risk Officer at General Bank of Canada & former VP O&T at Thomson Reuters. Global Board advisor on strategy and risk. Many organizations invest heavily in risk management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results